// App-Quantinova.ai

2567 : A phase I study of pemetrexed in combination with docetaxel in advanced solid tumor patients.

Researchers

Presenter

  • Lee D. Cranmer

Principal Investigators

  • Sherif S. Morgan

  • Terry Concannon

  • Kathy J Schmidt

  • Robin Snyder-Walker

  • Linda L. Garland

  • Amy S Bauland

  • Yrma Burruel

  • Jeanette S Cardenas

Medical Centers

  • University of Arizona Cancer Center, Tucson, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pemetrexed

  • Docetaxel

Outcome

  • Positive

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT01172028

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved